Gene polymorphisms in patients below 35 years of age who underwent coronary artery bypass surgery

Coronary Artery Disease

Volumn 17, Issue 1, 2006, Pages 35-39

  Tütün, Ufuk ^a,d   Aksöyek, Ayşen ^a   Ulus, Ahmet Tulga ^a   Misirlioǧlu, Müge ^b   Çiçekçioǧlu, Ferit ^a   Özişk, Kanat ^c   Ihsan Parlar, Ali ^a   Baran Budak, Ali ^a   Gedik, Selçuk ^a   Katrcoǧlu, Salih Fehmi ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b Metis Biotechnology Ltd   (Turkey)

^c ANKARA NUMUNE HOSPITAL   (Turkey)

^d NONE   (Turkey)

Author keywords

Coagulation; Coronary artery bypass grafting; Coronary artery disease; Interleukins; Young patients

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 6; PROTHROMBIN; TUMOR NECROSIS FACTOR ALPHA; BLOOD CLOTTING FACTOR 5; DNA;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; PRIORITY JOURNAL; AGAR GEL ELECTROPHORESIS; AGE; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; AGE FACTORS; ALLELES; CORONARY ARTERY BYPASS; CORONARY DISEASE; DNA; ELECTROPHORESIS, AGAR GEL; FACTOR V; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-6; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROGNOSIS; PROTHROMBIN; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646972320     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200602000-00006     Document Type: Article

References (41)

1. Simons LA. Interrelations of lipid and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol 1986; 57:5G-10G.
2. Irani-Hakime N, Tamin H, Elias G, Choueiry S, Kreidy R, Daccahe JL, Almawi WY. Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease. J Thromb Thrombolysis 2001; 11: 111-116.
3. Russo C, Girelli D, Olivieri O, Guarini P, Manzato F, Pizzolo F, et al. G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease. Circulation 2001; 103: 2436-2240.
4. Ranjith N, Pegoraro RJ, Rom L. Haemostatic gene polymorphisms in young Indian Asian subjects with acute myocardial infarction. Med Sci Monit 2003; 9:417-421.
5. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaulation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332:706-711.
6. Frishberg Y, Becker-Cohen R, Halle D, Feigin E, Eisenstein B, Halevy R, et al. Genetic polymorphism of the renin-angiotensin system and the outcome of focal segmental glomerulosclerosis in children. Kidney Int 1998; 54: 1843-1849.
7. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 39-translated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698-3700.
8. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, et al. Tumor necrosis factor (TNF) gene polymorphism influences TNFα production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113:401-406.
9. Helmy N, Maly FE, Bestmann L. Detection of the single-base substitution - 174 G→C in the interleukin-6 gene by real-time polymerase chain reaction: comment on the article by Moos et al. Arthritis Rheum 2001; 44:2213-2214.
10. Bertsch T, Zimmer W, Casarin W, Denz C, Quintel M, Fassbender K. Real-time PCR assay with fluorescent hybridization probes for rapid interleukin-6 promoter (174GC) genotyping. Clin Chem 2001; 47:1873-1874.
11. Fransen E, Maessen J, Dentener M, Senden N, Geskes G, Buurman W. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest 1998; 113:1290-1295.
12. Corbi P, Rahmati M, Delwail A, Potreau D, Menu P, Wijdenes J, Lecron JC. Circulating soluble gp130, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulation. Eur J Cardiothorac Surg 2000; 18:98-103.
13. Gandrille S, Alhenc-Gelas M, Aiach M. A rapid screening method for the factor V Arg506-Gln mutation. Blood Coagul Fibrinolysis 1195; 6:245-248.
14. McColl MD, Tait RC, Walker ID, McCall F, Conkie JA, Perry DJ. A symptomatic coinheritance of heterozygous plasminogen deficiency and factor V Leiden mutation. Blood Coagul Fibrinolysis 1997; 8:195-199.
15. Bertina RM. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem 1997; 43:1678-1683.
16. Tripodi A, Negri B, Bertina RM, Mannucci PM. Screening for the FV: Q506 mutation evaluation of thirteen plasma-based methods for their diagnostic efficacy in comparison with DNA analysis. Thromb Haemost 1997; 72:436-439.
17. Mahasandana C, Suvatte V, Marlar RA, Johnson MJ, Jacobson LJ, Hathaway WE. Neonatal purpura fulminans associated with homozygous protein S deficiency. Lancet 1990; 35:61.
18. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 6:1504-1508.
19. Mesci L. The prevalence of factor V Leiden (1691 G-A) mutation in Turkey. Turk J Pediatr 1997; 39:313-315.
20. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138:419-420.
21. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, et al. Interleukin-6 gene 2174G>C and 2572G>C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001; 21:1458-1463.
22. Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 1999; 99:2079-2084.
23. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101:1767-1772.
24. Zhu Y, Hojo Y, Ikeda U, Takahashi M, Shimada K. Interaction between monocytes and vascular smooth muscle cells enhances matrix metalloproteinase-1 production. J Cardiovasc Pharmacol 2000; 36:152-161.
25. Rus HG, Vlaicu R, Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996; 127:263-271.
26. Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M, et al. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 2000; 101:1372-1378.
27. Slazai C, Füst G, Duba J, Kramer J, Romics L, Prohazka Z, Csaszar A. Association of polymorphisms and allelic combinations in the tumour necrosis factor α complement MHC region with coronary artery disease. J Med Genetics 2002; 39:46-51.
28. Irwin MW, Mak S, Mann DL, Qu R, Penniger JM, Yan A, et al. Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium. Circulation 1999; 99:1492-1498.
29. Langrand WK, Niessen HWM, Wolbink GJ, Jaspars LH, Visser CA, Verheught FWA, et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 1997; 95:97-103.
30. Herrmann SM, Ricard S, Nicoud V, Mallet C, Arveiler D, Evans A, et al. Polymorphisms of the tumor necrosis factor-α gene, coronary heart disease and obesity. Eur J Clin Invest 1998; 28:59-66.
31. Hillarp A, Zoller B, Svensson PJ, Dahlback B. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 1997; 78:990-992.
32. Kyrle PA, Mannhalter C, Beguin S, Stumpflen A, Hirschl M, Weltermann A, et al. Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene. Arterioscler Thromb Vasc Biol 1998; 18:1287-1291.
33. Kohler HP, Stickland MH, Ossei-Gerning N, Carter AM, Mikkola H, Grant PJ. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79:8.
34. Ovali E, Karti SS, Pakdemir A, Yilmaz M, Önder E. Coexistence of prothrombic risk factors and its relation to left ventricular thrombus in acute myocardial infarction. Acta Cardiol 2004; 59:33-39.
35. Norlund L, Holm J, Zoller B, Ohlin AK. A common thrombomodulin amino acid dimorphism is not associated with myocardial infarction. Thromb Haemost 1997; 77:248-251.
36. Pfohl M, Koch M, Prescod S, Haase KK, Häring HU, Karsch KR. Angiotensin converting enzyme gene polymorphism, coronary artery disease and myocardial infarction. Eur Heart J 1999; 20:1318-1325.
37. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
38. Dzau V, Pratt R. Renin-angiotensin system. In: Fozzard HA, Haber HE, Jennings RB, Katz AM, Morgan HE, editors. The heart and cardiovascular system. New York: Raven Press; 1991. pp. 1817-1850.
39. Engel J, Kleine V, Schwahn C, Dahn JB, Eckel L, Retting R. Angiotensin I converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery. Chest 2002; 123:31-36.
40. Gardeman A, Weiâ T, Schwartz O, Eberbach A, Katz N, Herhlein FW, et al. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation 1995; 92:2796-2799.
41. Mayer B, Schunkert H. ACE gene polymorphism and cardiovascular diseases. Herz 2000; 25:1-6.